Inhalation

INH0826

Issue link: https://www.e-digitaleditions.com/i/1546206

Contents of this Issue

Navigation

Page 19 of 48

18 August 2026 Inhalation Particle characterization instruments Every breakthrough in inhalation begins with under- standing the particles that deliver it. Across formu- lation development, device optimization, quality control and regulatory science, accurate characteri- zation helps transform observations into knowledge. Drawing on decades of experience and an expanded Malvern Panalytical portfolio including key analyt- ical techniques for assessing particle size and shape, and aerated and flow energy as well as polymorphism and crystallinity, we are proud to support the inha- lation community through scientific collaboration, education and innovation. Together with research- ers, industry partners and regulatory stakeholders, we remain focused on advancing the measurement sci- ence that helps bring inhaled therapies to patients. Malvern Panalytical US: +1 978 872-4870 maria.lightfoot@malvernpanalytical.com www.malvernpanalytical.com Supporting evolving OINDP standards e February 2026 update to the EMA Guideline on the Pharmaceutical Quality of Inhalation and Nasal Medicinal Products formally incorporates spray pattern and plume geometry testing into OINDP development expectations, reinforcing the impor- tance of understanding aerosol performance early in the product lifecycle. As laboratories adapt to these evolving expectations, SprayVIEW ® Measurement System continues to be a trusted, industry-standard platform for quantitative spray characterization, providing the high-speed imaging and analytics needed to support product development and regu- latory submissions. Visit our website to learn more about guideline updates and their implications for product development. Proveris Laboratories US: +1 508 460-8820 contactus@proveris.com www.proverislabs.com Respiratory drug product development software Fusion Process Development (FPD) for respiratory drug product R&D is the perfect companion mod- ule to Fusion Inhaler Testing (FIT) for QC. FPD has automated Design of Experiments (DoE) and data modeling for formulation and process R&D. FPD enables you to create companion testing designs for your formulation and device design studies with full bi-directional Chromatography Data Software (CDS) testing automation. Automated CDS testing and data retrieval includes handling of complex data from cas- cade impaction testing and dissolution testing. And FPD operates under full regulatory compliance to maintain data integrity. S-Matrix ® US: +1 707 441-0406 sales@smatrix.com www.smatrix.com

Articles in this issue

Links on this page

view archives of Inhalation - INH0826